Document is current
Any future updates will be listed below
-
Authors
Angeloni, Allegra https://orcid.org/0000-0002-8104-718X
Hammond, Jillian M. https://orcid.org/0000-0002-4045-4571
Peters, Timothy J. https://orcid.org/0000-0003-3690-5293
Reis, Andre L. M. https://orcid.org/0000-0002-7300-1157
Kemp, Leah
Amos, Timothy G. https://orcid.org/0000-0002-5829-6655
Gamaarachchi, Hasindu
Humphries, Sam
Wilmott, Lynda A. https://orcid.org/0000-0002-8868-9433
Pal, Suranjana
Masamsetti, V. Pragathi https://orcid.org/0000-0002-0251-1707
Weatherstone, Megan
Ip, Chi Kin
Pazaky, Karina
Steel, Alice
Lyons, Ruth
Walters, Elly D.
Liu, Ning
Tam, Patrick https://orcid.org/0000-0001-6950-8388
Polo, Jose M. https://orcid.org/0000-0002-2531-778X
Waters, Paul D. https://orcid.org/0000-0002-4689-8747
Clark, Susan J. https://orcid.org/0000-0001-5925-5030
Richards, Linda J. https://orcid.org/0000-0002-7590-7390
Smith, Andrew D.
Lee, Heather J. https://orcid.org/0000-0002-6482-0337
Deveson, Ira W.
Griffith, Oliver W.
Skvortsova, Ksenia
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (2018114)
Department of Health | National Health and Medical Research Council (2026430)
- License Information
-
More Information
Article History
Received: 16 December 2025
Accepted: 21 May 2026
First Online: 15 June 2026
Competing interests
: I.W.D manages a fee-for-service sequencing facility at the Garvan Institute of Medical Research that is a customer of Oxford Nanopore Technologies but has no further financial relationship. H.G. and I.W.D. have previously received travel and accommodation expenses to speak at Oxford Nanopore Technologies conferences. The remaining authors declare no competing interests.
